The American Society of Hematology (ASH) is seeking public comments on two draft clinical practice guidelines: sickle cell disease (SCD)-related pain, and SCD-related transplantation.
The deadline for comments is May 13, 2019 and related materials can be found on the ASH Website.
In 2018, the first three of ASH’s series of five SCD guidelines opened for public comment covering SCD-related transfusion support, cardiopulmonary and kidney disease, and cerebrovascular disease. Anyone is welcome to review the draft recommendations and submit comments, including ASH members, non-member physicians and researchers, allied health professionals, representatives of medical societies, industry and insurance companies, patients, caregivers, and members of the public. Feedback received will be provided to the guideline panels for review. Comments will also be considered for implementation and dissemination efforts following publication, and future revision efforts.
Please let your colleagues and friends know about this public comment period. If you use social media, you may create your own tweet using #ASHGuidelines.
Reposted from SCD Coalition April Update